Fractyl Health (GUTS) Change in Inventory (2023 - 2025)
Fractyl Health (GUTS) reported Change in Inventory of -$73000.0 for Q1 2025, down 2333.33% quarter-over-quarter from -$3000.0 in Q4 2023.
Fractyl Health (GUTS) has 2 years of Change in Inventory data on file, last reported at -$73000.0 in Q1 2025.
- For the quarter ending Q1 2025, Change in Inventory changed N/A year-over-year to -$73000.0; the trailing twelve-month figure through Dec 2025 stood at -$73000.0 (changed N/A YoY), and the FY2025 full-year result was -$73000.0, changed N/A from the prior year.
- Change in Inventory for Q1 2025 stood at -$73000.0, down from -$3000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $73000.0 in Q1 2023 and bottomed at -$73000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -26.60 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -73,000.00 |
| Mar 31, 2025 | -73,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 73,000.00 |
| Mar 31, 2023 | 73,000.00 |